Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ETIHX vs SBIO overlap: 16% of top holdings shared

Bottom line

How much do ETIHX and SBIO overlap?

16% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 10.8% of ETIHX's assets and 12.4% of SBIO's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

ETIHXSBIO
Weight overlap (top 25)16%
Shared holdings4
Weight in shared holdings10.8%12.4%
Total positions9389
Expense ratio1.29%0.5%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings ETIHX and SBIO have in common

Holding% of ETIHX% of SBIOOverlap
Mirum Pharmaceuticals Inc3.47%3.90%3.47%
Kymera Therapeutics Inc3.22%4.23%3.22%
Celldex Therapeutics Inc2.16%1.33%1.33%
Apogee Therapeutics Inc1.93%2.93%1.93%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ETIHX

  1. Guardant Health Inc — 5.37%
  2. US Bank Mmda — 3.75%
  3. Abivax Sa — 2.94%
  4. BeLite Bio Inc — 2.83%
  5. Trevi Therapeutics Inc — 2.77%
  6. Mbx Biosciences Inc — 2.70%
  7. Vaxcyte Inc — 2.69%
  8. Cytokinetics Inc — 2.69%
  9. Argenx Se — 2.55%
  10. Ionis Pharmaceuticals Inc — 2.55%
  11. Insmed Inc — 2.40%
  12. Revolution Medicines Inc — 2.36%
  13. Avalyn Pharma Inc — 2.35%
  14. Immix Biopharma Inc — 2.24%
  15. Palvella Therapeutics Inc — 1.98%

Only in SBIO

  1. Alkermes Plc — 4.48%
  2. Celcuity Inc — 3.92%
  3. Spyre Therapeutics Inc — 3.68%
  4. Cg Oncology Inc — 3.35%
  5. Xenon Pharmaceuticals Inc — 2.90%
  6. Travere Therapeutics Inc — 2.77%
  7. Dianthus Therapeutics Inc — 2.64%
  8. Newamsterdam Pharma Co Nv — 2.47%
  9. Viking Therapeutics Inc — 2.41%
  10. Crinetics Pharmaceuticals Inc — 2.37%
  11. Acadia Pharmaceuticals Inc — 2.35%
  12. Edgewise Therapeutics Inc — 2.33%
  13. Denali Therapeutics Inc — 2.13%
  14. Oruka Therapeutics Inc — 1.81%
  15. Structure Therapeutics Inc — 1.78%

Asset mix

Asset typeETIHXSBIO
Stocks94.2%100.0%
Cash & short-term funds5.2%—
Preferred stock1.4%—
DO0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryETIHXSBIO
US90.2%80.2%
NL2.6%4.7%
KY1.0%4.7%
IE—4.5%
FR2.9%—
CA2.4%2.9%
BM2.0%—
BE—1.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do ETIHX and SBIO overlap?
About 16% by weight. 4 securities appear in both funds' top 25 holdings; they make up 10.8% of ETIHX's assets and 12.4% of SBIO's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do ETIHX and SBIO have in common?
The largest shared holdings are Mirum Pharmaceuticals Inc, Kymera Therapeutics Inc, Apogee Therapeutics Inc, Celldex Therapeutics Inc.
Should I own both ETIHX and SBIO?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, ETIHX or SBIO?
ETIHX is broader, with 93 positions versus 89 for SBIO. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.